表面活性剂介导的生物制造:促进微生物生物化学品生产的独特策略
Yunxin Yi1, Xiaofan Jin1, Moutong Chen2
1School of Food Science and Engineering, South China University of Technology, Guangzhou 510640, China.
Biotechnology advances
|May 4, 2024
概括
表面活性剂通过改变细胞膜和改善基质利用来增强微生物生物化学物质 (如颜料和氨基酸) 的产生. 本综述探讨了生物制造应用的表面活性剂特性和机制.
科学领域:
- 生物技术是生物技术.
- 生物化学 生物化学
- 微生物学 微生物学
背景情况:
- 生物化学品在医药和食品工业中至关重要,为合成化学品提供更安全的替代品.
- 表面活性剂可以与微生物相互作用,促进微生物代谢物的分泌和生物合成.
- 表面活性剂介导生物制造的广泛适用性和机制在很大程度上仍未得到充分探索.
研究的目的:
- 综合审查表面活性剂的特性及其在生物制造中的作用.
- 探索表面活性剂中介生物化学生产的各种应用场景.
- 阐明表面活性剂增强微生物代谢物产量的机制.
主要方法:
- 对表面活性剂的特性和生物制造中的应用进行文献综述.
- 分析涉及表面活性剂微粒和云点现象的机制.
- 研究表面活性剂对微生物细胞膜和代谢途径的影响.
主要成果:
- 表面活性剂通过云点和细胞增强色素,氨基酸和酒精的产生.
- 表面活性剂的两性改善了微生物对基质的利用,如纤维素和废物污泥.
- 表面活性剂改变细胞膜的透性和组成,促进代谢物分泌.
- 表面活性剂调节微生物的能量代谢,氧化还原状态和代谢流量,诱导代谢物合成.
结论:
- 表面活性剂为增强各种行业的微生物生物化学生产提供了一个有希望的策略.
- 了解表面活性剂机制为优化生物制造过程提供了新的见解.
- 这一审查扩大了表面活性剂在生产微生物生物化学品中的应用范围.
相关概念视频
01:22Bioreactor Controls-III
67
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67
01:14Scale-Up Processes
105
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
105
01:27Upstream Processing
97
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
97
01:30Production of Pharmaceuticals
94
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
94
01:18Production of Biopesticides
108
Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...
108
01:25Biofuels
107
The microbial conversion of organic matter into biofuels holds potential as a renewable energy source. Among biofuel sources, microalgae are recognized as a highly efficient and adaptable feedstock for biodiesel production, owing to their rapid biomass accumulation, elevated lipid productivity, and capacity to proliferate in diverse aquatic systems, including freshwater, marine, and wastewater habitats. Unlike terrestrial crops, microalgae do not compete for land and can achieve significantly...
107